Main > ONCOLOGY (**) > Brain Cancer>GBM>Recurrent (R) * > Treatment > USA. G. BevacizuMAb

---

USA. G. BevacizuMAb's subsections
(*) USA Approval Date: 2017. 12.05.
Company
TradeMark

USA. G. BevacizuMAb's products
This section has no products